Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review-Reference-Cited by-同舟云学术

Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review

Published:2018-01 Issue:1 Volume:14 Page:66-73
ISSN:1550-7289
Container-title:Surgery for Obesity and Related Diseases
language:en
Short-container-title:Surgery for Obesity and Related Diseases

Author:

Souto Katia P.,Meinhardt Nelson G.,Ramos Maurício J.,Ulbrich-Kulkzynski Jane M.,Stein Airton T.,Damin Daniel C.

Publisher

Elsevier BV

Subject

Surgery

Reference41 articles.

1. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis;Mummadi;Clin Gastroenterol Hepatol,2008

2. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world;Sayiner;Clin Liver Dis,2016

3. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: “NASHOST” prospective observational trial;Praveen Raj;Surg Obes Relat Dis,2015

4. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients;Lassailly;Gastroenterol,2015

5. Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance;Glen;BMJ,2016

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. American society for metabolic and bariatric surgery: intra-operative care pathway for minimally invasive Roux-en-Y gastric bypass;Surgery for Obesity and Related Diseases;2024-10

2. Comparison of different liver fibrosis scores following sleeve gastrectomy;2024-09-06

3. Liver Tissue Proteins Improve the Accuracy of Plasma Proteins as Biomarkers in Diagnosing Metabolic Dysfunction‐Associated Steatohepatitis;PROTEOMICS – Clinical Applications;2024-07-28

4. Obesity in Prediabetic Patients: Management of Metabolic Complications and Strategies for Prevention of Overt Diabetes;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-05-20

5. DIAGNOSTIC ACCURACY OF THE NON-INVASIVE MARKERS NFLS, NI-NASH-DS, AND FIB-4 FOR ASSESSMENT OF DIFFERENT ASPECTS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN INDIVIDUALS WITH OBESITY: CROSS-SECTIONAL STUDY;Arquivos de Gastroenterologia;2024